Elevated expression of RCC2 was correlated with poor prognosis in basal cell carcinoma (BCC) 19, colorectal cancer 20, gastric cancer 21, lung cancer 22-24 and ovarian cancer 23. This evidence concerns the gene RCC2 and lung carcinoma.